Prøve GULL - Gratis
Multipurpose fluid bed processors from Romaco Innojet in use at Klocke Pharma-Service GmbH
Express Pharma
|June 2025
When it comes to producing and coating granulates, contract manufacturer Klocke Pharma-Service GmbH puts its trust in fluid bed technology from Romaco Innojet. With its wide range of applications, short processing times, linear scalability, sparing use of raw materials and reliable, energy-efficient production processes, the VENTILUS technology is tailor-made for the requirements of a contract manufacturing organisation
-

The Klocke Group is one of Europe's leading contract manufacturing and packaging suppliers. Klocke Pharma-Service GmbH, at home in Appenweier in south-west Germany, processes a variety of raw materials into powder granulates and pellets, mainly for compression into tablets. The contract manufacturer first started using VENTILUS fluid bed processors from Innojet, a Romaco Group company, in 2014 and has continuously enlarged its stock of these technologies ever since.
Klocke presently has six Innojet-built fluid bed processors at its disposal for carrying out wet granulation processes with aqueous and solvent-based binder media as well as for drying and pellet coating. In addition to a VENTILUS® pilot plant for batch sizes up to 50 litres, three production plants for up to 400 litres and two for up to 800 litres are in use today. The systems are designed to be compatible as regards product filters and spare parts, and upscaling from a smaller processing machine to a larger one is a simple matter.
“The VENTILUS fluid bed processors from Romaco Innojet helped us achieve a technological leap forward”, reports Alexander Pergande, Managing Director Operations at Klocke Pharma-Service. “The uniform flow conditions in the machines and the precise bottom spray technology mean we can produce granulates with a more homogeneous particle size distribution and hence better flowability, leading to higher tabletting speeds. What's more, our service portfolio has been expanded on the basis of this technology, and we're now also in a position to coat pellets or film-coat micro-tablets, which we couldn't do with top spray technology.”

Denne historien er fra June 2025-utgaven av Express Pharma.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Express Pharma

Express Pharma
Flexotherm Heating Tapes & Cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
October 2025

Express Pharma
DRIVING INDIA'S INNOVATION EDGE
Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma Inc's shift from generics to innovation and global leadership
16 mins
October 2025

Express Pharma
Al compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging Al across nearly every aspect of commercialisation, from market forecasting and personalised marketing to dynamic pricing and beyond. In this article, Neha Aathavale takes the pulse of the industry to explore who is taking note and how companies are beginning to put Al into action in their commercial operations
7 mins
October 2025

Express Pharma
PRIME NEO: New age doors from Gandhi Automation
Gandhi Automations presents the multi-composites, high-performance door PRIME NEO for clean environments. Complete Washable, Greater Sealing and Pressure Resistant.
1 mins
October 2025

Express Pharma
Unani Medicine: At crossroads of tradition and modernity
Manufacturers, academic institutions and research councils are working together to elevate Unani medicine through clinical validation and policy alignment with international standards, finds Swati Rana
7 mins
October 2025

Express Pharma
Single-Use Technologies in Biologics Manufacturing: Benefits, Challenges, and Growing Demand
The biopharmaceutical industry is increasingly adopting single-use technology (SUT) to achieve flexibility, cost efficiency, and faster time-to-market. Compared with stainless steel systems, SUT reduces capital investment, eliminates cleaning and sterilization steps, lowers contamination risk, and shortens production timelines.
1 min
October 2025

Express Pharma
Sustainable packaging with Romaco and Liveo Research
Recycable blister packs
3 mins
October 2025

Express Pharma
With India soon to be three times the population of the EU, it makes perfect sense to have manufacturing here
As part of Sweden's Focus Asia programme, a high-level SME delegation recently visited India to strengthen bilateral ties and explore collaborations across sectors including pharma, biotech and others. Building on the momentum of the \"Time for Sweden\" event, the visit underscored Sweden's commitment to innovation, sustainability, and co-creation with India. Among the delegation was Emil Alexander Byström, CEO of SpinChem AB, who in an interaction with Kalyani Sharma shared his insights on how advanced Swedish technologies like biocatalysis and the company's patented Rotating Bed Reactor (RBR) can accelerate India's pharma and biotech innovation journey while supporting sustainable growth.
3 mins
October 2025

Express Pharma
Cell therapy's next chapter: Industry embraces in-vivo innovation
Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that cell therapy is entering a bold new phase in 2025 as the industry shifts from complex, lab-based ex vivo CAR-T to faster, more accessible in vivo CAR-T innovations. This approach promises to expand access, lower costs, and potentially tackle solid tumors and autoimmune diseases
4 mins
October 2025

Express Pharma
Research misconduct ...can delay meaningful and reliable discoveries
Dr Gráinne McNamara, Research Integrity/Publication Ethics Manager, S. Karger AG explores how research misconduct, peer review fraud slow down pharma research. Of particular concern to India is the fact that India-based researchers constitute 5 per cent of articles in life sciences retracted between 1976-2023. India-based researchers also have one of the highest rates of retraction relative to the overall publication output. Over an email exchange with Viveka Roychowdhury, she details how publishers are now deploying AI tools, some of which contributed to the problem in the first place, to detect and avert fraudulent research submissions
6 mins
October 2025
Listen
Translate
Change font size